Enhance your nephrology practice with CME and tools focused on kidney medicine.
Individualized Management of Hyperkalemia: The Role of Potassium Binders in Patients With Cardiorenal Disease
Ellie Kelepouris, MD, FACP, FAHA
Quantifying CKD-aP: Tools for Better Care
James Burton, DM, FRCP
Emilio Sanchez, MD, PhD
Is CKD-aP Hiding in Your Dialysis Center?
Elevating CKD-aP Care: New Frontier
Lucio Manenti, MD, PhD
Improving Sleep and Mental Health in Patients with CKD-aP
Leonie Kraft, MD
The Patient-Clinician Connection in Managing CKD-aP
Precision Medicine in IgAN: A Deep Dive into Biomarkers, Evolving Guidelines, and Therapeutic Frontiers
Chee Kay Cheung, MBCHB, MRCP, PHD
Raphael Duivenvoorden, MD, PhD
Optimizing IgAN Care: Sparsentan’s Role Amid the Latest KDIGO Guideline Updates
Jürgen Floege, MD
CKD-aP: Beyond the Surface
Kappa-Opioid Settings: Real-World Evidence Insights
Future Directions in Managing Hyperkalemia in CKD and HF
Javed Butler, MD, MPH, MBA
Case-Based Application: Optimizing RAASi/MRA Therapy with Potassium Binders
Patrick Rossignol, MD, PhD
Implementing Potassium Binders: Practical Dosing and Long-Term Follow Up
Oral Potassium Binders: A Novel Approach to Curb Hyperkalemia in CKD and HF
Potassium Binders in Practice: Clinical Trial Evidence
Optimizing IgAN Care: Achieving Lower Proteinuria Targets With Combination Therapy
Jonathan Barratt, MD, PhD
Sydney Tang, MBBS, MD
Optimizing Hyperkalemia Management: Clinical Implications and Risk Assessment
Guidelines Update: RAASi/MRA Therapy in CKD and HF Management
Treatment Revolution in IgA Nephropathy
Shikha Wadhwani, MD
Dana Rizk, MD
Practical Strategies for Optimizing Outcomes in Patients with Iron Deficiency and Heart Failure
Robert J. Mentz, MD, FHFSA, FACC
Piotr Ponikowski, MD, PhD, FESC, FHFA
FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
Stefan D. Anker, MD, PhD
Mahir Karakas, MD, PhD, MBA
Pearls of Wisdom: Optimizing Hyperkalemia Management in Patients with CKD
Matthew R. Weir, MD
Nihar Desai, MD
Elevating Care for Patients With Severe Renal Disease in AAV
Silke R. Brix, MD, MRCP, SCPR
Andreas Kronbichler, MD
Tailoring Treatment for Optimal Outcomes in Patients With AAV
Bernhard Hellmich, MD
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Kidney Academy… but how about a more personalized experience?
Press cancel to remain on Global Kidney Academy. Press the link below or the continue button to keep going.